IRF1 and melanoma: Enhanced IRF1 promoter methylation observed in TRIM28HIGH expressing melanoma patients is in line with the previous report, although further studies are needed to prove the versatility of TRIM28-mediated repression of other IRF members in “stemness high/immune low” melanomas.